Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmozyme is a private molecular diagnostics and biotechnology company based in Sunnyvale, California. The company develops proprietary low-contamination enzyme production technology and sells PCR and RT-qPCR reagents, polymerases, and multiplex diagnostic panels for research and laboratory testing applications. Its core products include Crystal Taq DNA Polymerase, Samurai Taq DNA Polymerase, COVID-19 RT-qPCR kits, respiratory pathogen panels, and a urinary tract infection qPCR panel. Pharmozyme emphasizes extraction-free and easy-to-use workflows, with a quality system designed around ISO 13485:2016. The business appears to operate primarily as a diagnostics and reagent supplier rather than as a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmozyme.